Strategic Opportunity in COMPASS Pathways Amid Extended Phase 3 Trials and Conservative Price Target
Canaccord Genuity analyst Sumant Kulkarni has maintained their bullish stance on CMPS stock, giving a Buy rating on November 4. Sumant ...
Compass Diversified price target raised to $28 from $26 at BofA
BofA analyst Eric Dray raised the firm’s price target on Compass Diversified (CODI) to $28 from $26 and keeps a Buy rating on the shares ...